Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Animal Welfare

Dáil Éireann Debate, Tuesday - 5 March 2019

Tuesday, 5 March 2019

Ceisteanna (347, 348, 349, 350, 351, 352, 353, 354)

Catherine Martin

Ceist:

347. Deputy Catherine Martin asked the Minister for Health the number of animals and the species that will be used in a large animal test facility (details supplied); and if he will make a statement on the matter. [10771/19]

Amharc ar fhreagra

Catherine Martin

Ceist:

348. Deputy Catherine Martin asked the Minister for Health the foreseen testing purposes for the use of animals in a large animal test facility (details supplied) other than those already outlined; the definition of new animal model systems; if the development of new lines of genetically-modified animals for research purposes is foreseen; if the creation of genetically-modified animals that are able to carry specific human diseases is foreseen; and if he will make a statement on the matter. [10772/19]

Amharc ar fhreagra

Catherine Martin

Ceist:

349. Deputy Catherine Martin asked the Minister for Health if his attention or that of the HSE have been drawn to and whether it is considering the human relevant humane alternative approaches to pharmaceutical and other testing; and if he will make a statement on the matter. [10773/19]

Amharc ar fhreagra

Catherine Martin

Ceist:

350. Deputy Catherine Martin asked the Minister for Health the success rates of animal experimentation and testing; and if he will make a statement on the matter. [10774/19]

Amharc ar fhreagra

Catherine Martin

Ceist:

351. Deputy Catherine Martin asked the Minister for Health if he has taken into consideration his responsibility to promote the development and uptake of alternatives to the use of animals under article 47 of Directive 2010/63/EU for the protection of animals used for scientific purposes. [10775/19]

Amharc ar fhreagra

Catherine Martin

Ceist:

352. Deputy Catherine Martin asked the Minister for Health if the animals in a test facility (details supplied) will be sold on to other facilities here or abroad; and if he will make a statement on the matter. [10776/19]

Amharc ar fhreagra

Catherine Martin

Ceist:

353. Deputy Catherine Martin asked the Minister for Health the locations in which medical device preclinical trials are being carried out here in view of the comment in a tender (details supplied); and if he will make a statement on the matter. [10777/19]

Amharc ar fhreagra

Catherine Martin

Ceist:

354. Deputy Catherine Martin asked the Minister for Health the number of medical devices tested on animals here each year; the percentage of tests legally required by the EU; the number of tests that lead on to human clinical trials; the success rates of the tests; and if he will make a statement on the matter. [10778/19]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 347 to 354, inclusive, together.

The Health Products Regulatory Authority (HPRA) is the competent authority in Ireland responsible for the implementation of EU legislation for the protection of animals used for scientific purposes. The Deputy's questions have been referred to the HPRA for a detailed response, and I have asked my officials to respond directly to the Deputy once that response is received in the Department.

Barr
Roinn